Nicole Germino
Stock Analyst at Truist Securities
(3.64)
# 724
Out of 5,182 analysts
23
Total ratings
65%
Success rate
39.72%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Nicole Germino
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSM Insmed | Maintains: Buy | $126 → $139 | $135.98 | +2.22% | 10 | Aug 14, 2025 | |
| CATX Perspective Therapeutics | Maintains: Buy | $10 → $8 | $4.27 | +87.35% | 3 | May 14, 2025 | |
| SGMO Sangamo Therapeutics | Maintains: Buy | $7 → $5 | $0.21 | +2,280.95% | 5 | Jan 23, 2025 | |
| ASMB Assembly Biosciences | Downgrades: Hold | $132 → $24 | $27.52 | -12.79% | 3 | Oct 24, 2022 | |
| FBRX Forte Biosciences | Downgrades: Hold | n/a | $26.74 | - | 2 | Sep 3, 2021 |
Insmed
Aug 14, 2025
Maintains: Buy
Price Target: $126 → $139
Current: $135.98
Upside: +2.22%
Perspective Therapeutics
May 14, 2025
Maintains: Buy
Price Target: $10 → $8
Current: $4.27
Upside: +87.35%
Sangamo Therapeutics
Jan 23, 2025
Maintains: Buy
Price Target: $7 → $5
Current: $0.21
Upside: +2,280.95%
Assembly Biosciences
Oct 24, 2022
Downgrades: Hold
Price Target: $132 → $24
Current: $27.52
Upside: -12.79%
Forte Biosciences
Sep 3, 2021
Downgrades: Hold
Price Target: n/a
Current: $26.74
Upside: -